| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 84781 |
DOTA-D-Phe(1)-Tyr(3)-Octreotide |
175 |
h |
2024-12-19 |
| 84782 |
cas:55750-63-5，Mal-heptanoic NHS ester |
205 |
zyl |
2024-12-19 |
| 84783 |
DOTA-Fab-PEG24-EGF DOTA-PEG修饰曲妥珠单抗Fab片段偶联表皮生长因子 |
177 |
h |
2024-12-19 |
| 84784 |
cas:663599-10-8，DMAC-SPP |
190 |
zyl |
2024-12-19 |
| 84785 |
多甲基化的1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸(DOTA)配体 |
218 |
h |
2024-12-19 |
| 84786 |
PEG-pGlu(DOTA)8-LA4 |
105 |
h |
2024-12-19 |
| 84787 |
cas:937025-17-7，2,5-Dioxopyrrolidin-1-yl 2-oxo-6,9,12,15-tetraoxa-3-thiaoctadecan-18-oate |
192 |
zyl |
2024-12-19 |
| 84788 |
DOTA-Hyd-TRP PET示踪剂 |
171 |
h |
2024-12-19 |
| 84789 |
Ga-DOTATOC Ga-DOTA-D-Phe-Tyr-奥曲肽 |
249 |
h |
2024-12-19 |
| 84790 |
cas:1226371-65-8，N-(2-(2,5-Dimethylphenoxy)ethyl)-4-formylbenzamide |
138 |
zyl |
2024-12-19 |
| 84791 |
DOTA-ALN DOTA-阿仑膦酸盐 |
147 |
h |
2024-12-19 |
| 84792 |
氨氯地平DOTA偶联物 DOTA-Amlodipine |
278 |
h |
2024-12-19 |
| 84793 |
cas:906564-59-8，Propargyl-C2-NHS ester |
159 |
zyl |
2024-12-19 |
| 84794 |
DOTA-Gp2-EGFR DOTA螯合剂标记结合表皮生长因子受体EGFR靶向Gp2 |
147 |
h |
2024-12-19 |
| 84795 |
cas:894095-98-8，β-D-glucuronide-pNP-carbonate |
141 |
zyl |
2024-12-19 |
| 84796 |
DOTA结合肽功能化金纳米粒子 |
167 |
h |
2024-12-19 |
| 84797 |
90Y-DOTA-Bn 钇-90-DOTA-铃蟾肽 |
238 |
h |
2024-12-19 |
| 84798 |
cas:85916-13-8，NH-bis(C1-Boc)，亚氨基二乙酸二异丁酯 |
195 |
zyl |
2024-12-19 |
| 84799 |
Anti-CD19 (clone huB4)-Mc-MMAF-ADC分子 |
112 |
zyl |
2024-12-19 |
| 84800 |
Boc-Val-Cit-PAB-PNP cas:870487-10-8 |
124 |
zyl |
2024-12-19 |
| 84801 |
cas:2353409-70-6 MMAF-methyl ester |
235 |
zyl |
2024-12-19 |
| 84802 |
DOTA-ipilimumab 螯合剂DOTA缀合单克隆抗体ipilimumab |
170 |
h |
2024-12-19 |
| 84803 |
双功能单膦酸Ln-DOTA衍生物 |
178 |
h |
2024-12-19 |
| 84804 |
Cu-DOTA-阿伦膦酸盐 Cu-DOTA-alendronate |
166 |
h |
2024-12-19 |
| 84805 |
Mc-3377的介绍 |
139 |
zyl |
2024-12-19 |
| 84806 |
Endo-BCN-PEG4-Val-Cit-PAB-MMAF的介绍 |
132 |
zyl |
2024-12-19 |
| 84807 |
(DOTA)n-PAMAM-[尼妥珠单抗-F(ab’)2]的缀合物 |
152 |
h |
2024-12-19 |
| 84808 |
cas:2055041-39-7 Mal-PEG4-Val-Cit-PAB-OH |
173 |
zyl |
2024-12-19 |
| 84809 |
DBCO-PEG3-Val-Cit-PAB-PNP的介绍 |
199 |
zyl |
2024-12-19 |
| 84810 |
(DOTA)5-十氢赖氨酸(DOTA)5-decalysine |
198 |
h |
2024-12-19 |
| 84811 |
DOTA-HPMA缀合物 DOTA共轭N-(2-羟丙基)甲基丙烯酰胺聚合物 |
167 |
h |
2024-12-19 |
| 84812 |
G3-cNGR肽缀合物 |
202 |
h |
2024-12-19 |
| 84813 |
DOTA-USMSN DOTA偶联介孔二氧化硅纳米颗粒 |
148 |
h |
2024-12-19 |
| 84814 |
Gd-DOTA-CC9 环肽CC9偶联Gd-DOTA |
206 |
h |
2024-12-19 |
| 84815 |
DOTA-尼妥珠单抗缀合物 DOTA-NIM |
119 |
h |
2024-12-19 |
| 84816 |
DOTA功能化杯[4]芳烃 DOTA-Calix[4]arenes |
144 |
h |
2024-12-19 |
| 84817 |
DOTA-Modified 2-Hydroxypropyl-β-Cyclodextrin/4-Sulfobutyl Ether-β-Cyclodextrin-Based Polyrotaxanes |
103 |
h |
2024-12-19 |
| 84818 |
CQDs-DOTA-Eu 铕-DOTA螯合物功能化碳量子点 |
216 |
h |
2024-12-19 |
| 84819 |
DOTA-曲普瑞林 DOTA-TRP |
147 |
h |
2024-12-19 |
| 84820 |
DOTA-Boron-ENPY 大环DOTA偶联16氨基酸的NPY衍生物 |
193 |
h |
2024-12-19 |
| 84821 |
DOTA-CDP1 DOTA功能化凯萨林菌素衍生肽 |
167 |
h |
2024-12-19 |
| 84822 |
Fe3O4@SiO2-APTES-DOTA-Teniposide 氧化铁@二氧化硅核壳纳米粒子偶联DOTA分子共轭替尼泊苷药物 |
231 |
h |
2024-12-19 |
| 84823 |
DOTA-吉西他滨 DOTA-gem |
248 |
h |
2024-12-19 |
| 84824 |
DOTA缀合的TMVP1肽 DOTA-TMVP1 |
130 |
h |
2024-12-19 |
| 84825 |
DOTA-NHS-ester偶联16-氨基-1-十六烷硫醇盐酸盐 |
165 |
h |
2024-12-19 |
齐岳微信公众号
官方微信
库存查询